ICOSLG Antikörper (AA 19-258)
ICOSLG
Reaktivität: Human
WB, ELISA, FACS, Neut
Wirt: Maus
Monoclonal
8H104
unconjugated
Produktnummer ABIN3172719
-
-
Target
Alle ICOSLG Antikörper anzeigen
-
ICOSLG
(Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Bindungsspezifität
-
AA 19-258
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Monoklonal
-
Konjugat
-
Dieser ICOSLG Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA, Flow Cytometry (FACS), Neutralization (Neut)
-
Kreuzreaktivität
-
Human
-
Kreuzreaktivität (Details)
-
Calculated cross reactivity: Hu
-
Produktmerkmale
-
ICOS Ligand (CD275, Inducible T cell co-stimulator ligand, B7-H2, B7 homolog 2, B7-like protein Gl50, B7 related protein 1, B7H2, B7RP-1, B7RP1, GL50, ICOS LG , ICOSLG, KIAA0653, LICOS, Transmembrane protein B7 H2 ICOS ligand)
-
Aufreinigung
-
Purified by Protein A affinity chromatography.
-
Endotoxin-Niveau
-
Endotoxin: <0.1EU/ug (LAL)
-
Immunogen
-
Recombinant protein corresponding to Asp19-Ser258 from human ICOS Ligand expressed in NSO cells (O75144).
-
Klon
-
8H104
-
Isotyp
-
IgG2b
-
Top Product
-
Discover our top product ICOSLG Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working conditions should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Lyophilized
-
Rekonstitution
-
Reconstitute with 1 mL sterile PBS.
-
Buffer
-
Supplied as a lyophilized powder from PBS, pH 7.4, 5 % trehalose.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
-20°C
-
-
Target
-
ICOSLG
(Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Andere Bezeichnung
-
ICOS Ligand (ICOSLG Produkte)
-
Pathways
-
Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
-